BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bonifati C, Lora V, Graceffa D, Nosotti L. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World J Gastroenterol 2016; 22(28): 6444-6455 [PMID: 27605880 DOI: 10.3748/wjg.v22.i28.6444]
URL: https://www.wjgnet.com/1007-9327/full/v22/i28/6444.htm
Number Citing Articles
1
Nawaf AlMutairi, Hesham Alaadin Abouzaid. Safety of biologic agents for psoriasis in patients with viral hepatitisJournal of Dermatological Treatment 2018; 29(6): 553 doi: 10.1080/09546634.2018.1430301
2
Huijuan Shi, Dongmei Chen, Jiawei Si, Qian Zou, Yatao Guo, Jiayu Yu, Cheng Li, Fang Wang. Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic PsoriasisDermatology and Therapy 2024; 14(6): 1659 doi: 10.1007/s13555-024-01181-5
3
Valeria Manfreda, Maria Esposito, Elena Campione, Luca Bianchi, Alessandro Giunta. Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infectionsPostgraduate Medicine 2019; 131(3): 239 doi: 10.1080/00325481.2019.1575613
4
Galina I. Gridneva, Boris S. Belov, Evgeniia S. Aronova. Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A reviewTerapevticheskii arkhiv 2024; 96(5): 523 doi: 10.26442/00403660.2024.05.202707
5
Matteo Megna, Gabriella Fabbrocini, Lucia Gallo, Angela Patrì, Angelo Ruggiero. A Case of Chronic HCV Infection Reactivation in a Psoriasis Patient Treated with GuselkumabCurrent Drug Safety 2022; 17(4): 390 doi: 10.2174/1574886317666220307112926
6
Nicola Imperatore, Fabiana Castiglione, Antonio Rispo, Anna Sessa, Nicola Caporaso, Filomena Morisco. Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel DiseasesFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00867
7
Francesca Peccerillo, Giulia Odorici, Giovanni Pellacani, Andrea Conti. Secukinumab: A positive outcome in a patient with severe psoriasis and HBV-HCV co-infectionDermatologic Therapy 2018; 31(4): e12601 doi: 10.1111/dth.12601
8
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical ConsiderationsAmerican Journal of Clinical Dermatology 2019; 20(6): 829 doi: 10.1007/s40257-019-00457-3
9
Xinyu Wang, Ming Zhang, Yu Chen, Yirong Liu, Yan Yu, Xiaojie Huang, Yanqing Gao. Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-AnalysisDermatology and Therapy 2022; 12(3): 655 doi: 10.1007/s13555-022-00682-5
10
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic PatientsBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
11
Ayman Abdelmaksoud, Michelangelo Vestita. Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!Dermatologic Therapy 2019; : e12929 doi: 10.1111/dth.12929
12
Leena Chularojanamontri, Supot Nimanong, Chanisada Wongpraparut, Narumol Silpa‐Archa, Chayada Chaiyabutr, Norramon Charoenpipatsin. Impact of long‐term systemic treatment for psoriasis on liver disease in psoriasis patients with coexisting hepatitis B virus infectionDermatologic Therapy 2020; 33(6) doi: 10.1111/dth.14008
13
Y T Lim, S Robinson, M M Tang. Liver disease among patients with psoriasis: the Malaysian Psoriasis RegistryClinical and Experimental Dermatology 2023; 48(5): 476 doi: 10.1093/ced/llad013
14
Eingun James Song, Patrick Whitman, Jonmichael Samsel. The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infectionJAAD Case Reports 2021; 8: 37 doi: 10.1016/j.jdcr.2020.12.006
15
Soumi Sukla, Syamal Roy, Shyam Sundar, Subhajit Biswas. Leptomonas seymouri narna-like virus 1 and not leishmaniaviruses detected in kala-azar samples from IndiaArchives of Virology 2017; 162(12): 3827 doi: 10.1007/s00705-017-3559-y
16
Giovanni Damiani, Chiara Franchi, Paolo Pigatto, Andrea Altomare, Alessia Pacifico, Stephen Petrou, Sebastiano Leone, Maria Caterina Pace, Marco Fiore. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agentsWorld Journal of Hepatology 2018; 10(2): 329-336 doi: 10.4254/wjh.v10.i2.329
17
Khalid A. Alnaqbi, Suad Hannawi, Rajaie Namas, Waleed Alshehhi, Humeira Badsha, Jamal Al‐Saleh. Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab EmiratesInternational Journal of Rheumatic Diseases 2022; 25(10): 1107 doi: 10.1111/1756-185X.14406
18
Elżbieta Halina Kłujszo, Dorota Zarębska‐Michaluk, Beata Kręcisz, Anna Witkowska. Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infectionDermatologic Therapy 2022; 35(3) doi: 10.1111/dth.15274
19
Mariantonietta Pisaturo, Giovanni Di Caprio, Federica Calò, Federica Portunato, Salvatore Martini, Nicola Coppola. Management of HBV reactivation in non-oncological patientsExpert Review of Anti-infective Therapy 2018; 16(8): 611 doi: 10.1080/14787210.2018.1505501
20
J.L.W. Lambert, S. Segaert, P.D. Ghislain, T. Hillary, A. Nikkels, F. Willaert, J. Lambert, R. Speeckaert. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)Journal of the European Academy of Dermatology and Venereology 2020; 34(9): 1914 doi: 10.1111/jdv.16683
21
Eric Santana, Ken S. Rosenthal. Ablative Treatment of Inflammatory and Other Diseases With Monoclonal Antibodies (Mabs) or Janus Kinases (Nibs) Increases Risk for InfectionInfectious Diseases in Clinical Practice 2023; 31(6) doi: 10.1097/IPC.0000000000001317
22
Jashin J. Wu, Joseph F. Merola, Steven R. Feldman, Alan Menter, Mark Lebwohl. Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available EvidenceDermatology and Therapy 2020; 10(3): 351 doi: 10.1007/s13555-020-00373-z
23
Alondra Esthefanía Llamas Domínguez, Julio Augusto Palma Zapata, Jose Luis Parra-Herrera, Juan Manuel Diaz, Silvia Denise Ponce-Campos. Autoimmune interstitial lung disease and hepatitis C, an interesting association: Two case reportsMedical Reports 2024; 5: 100066 doi: 10.1016/j.hmedic.2024.100066
24
J. M. Carrascosa, E. Del-Alcazar. New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their managementExpert Review of Clinical Immunology 2018; 14(4): 259 doi: 10.1080/1744666X.2018.1454835
25
Marius Rademaker, Karen Agnew, Nicholas Anagnostou, Megan Andrews, Katherine Armour, Christopher Baker, Peter Foley, Kurt Gebauer, Monisha Gupta, Gillian Marshman, Diana Rubel, John Sullivan, Li‐Chuen Wong. Psoriasis and infection. A clinical practice narrativeAustralasian Journal of Dermatology 2019; 60(2): 91 doi: 10.1111/ajd.12895
26
Kavita Darji, Daniel J. No, Mina Amin, Jashin J. Wu. Clinical Cases in Psoriasis2017; : 151 doi: 10.1007/978-3-319-52779-6_20
27
Kerasia-Maria Plachouri, Sophia Georgiou. Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosisJournal of Dermatological Treatment 2019; 30(7): 668 doi: 10.1080/09546634.2018.1544413
28
James Cheng‐Chung Wei, Chin‐Hsiu Liu, Jui‐Cheng Tseng, Lin‐Fen Hsieh, Chun‐Hsiung Chen, Hsin‐Hua Chen, Hung‐An Chen, Ying‐Chou Chen, Chung‐Tei Chou, Hsien‐Tzung Liao, Yi‐Chun Lin, Shue‐Fen Luo, Deng‐Ho Yang, Kai‐Jieh Yeo, Wen‐Chan Tsai. Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritisInternational Journal of Rheumatic Diseases 2020; 23(1): 7 doi: 10.1111/1756-185X.13752
29
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nagral, Amarender S. Puri, Padaki N. Rao, Neeraj Saraf, Vivek A. Saraswat, Sanjeev Sehgal, Praveen Sharma, Koticherry T. Shenoy, Manav Wadhawan. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsJournal of Clinical and Experimental Hepatology 2018; 8(4): 403 doi: 10.1016/j.jceh.2018.06.010
30
Kevin K. Wu, Michael P. Lee, Jashin J. Wu. Clinical Cases in Psoriasis2019; : 139 doi: 10.1007/978-3-030-18772-9_19
31
Matteo Megna, Giuseppe Lauletta, Nello Tommasino, Antonia Salsano, Teresa Battista, Angelo Ruggiero, Fabrizio Martora, Luca Potestio. Management of Psoriasis Patients with Serious Infectious DiseasesAdvances in Therapy 2024; 41(6): 2099 doi: 10.1007/s12325-024-02873-2
32
Anwar Al Hammadi, Muna Al Murrawi, Huda R. Ali, Ashraf M. Reda, Hussein A. Dayem, Jawaher Alnaqbi, Zaidoon Abdelhadi, Samir Hantirah, Ayman Alnaeem, Fatima Al. Marzooqi, Amani Alfalasi, Fatima Albreiki, Khadija Aljefri, Faiza Al Ali. Systemic Treatments for Adult Patients with Moderate-to-Severe Psoriasis: Consensus Statements for the United Arab EmiratesNew Emirates Medical Journal 2022; 3(1): 17 doi: 10.2174/02666211213145047
33
Yuhan Wang, Ping Zhang, Yu Lv, Yu Deng, Ming Yao, Lin Wang, Guangtao Pan. Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature ReviewClinical, Cosmetic and Investigational Dermatology 2023; : 3487 doi: 10.2147/CCID.S439110
34
Peter Yi Ch’en, Sterling Farrer, Lauren Miranda-Cacdac, Eingun James Song. The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: A case seriesJAAD Case Reports 2022; 30: 1 doi: 10.1016/j.jdcr.2022.09.023
35
Katie A. O’Connell, Alexandra Mari, Abby S. Van Voorhees. Biologic Therapy for PsoriasisUpdates in Clinical Dermatology 2022; : 9 doi: 10.1007/978-3-030-92938-1_2
36
Alexandra M. G. Brunasso, Martina Burlando, Fabrizio Amoruso, Luisa Arancio, Giovanna Malara, Raffaella Manzo, Maria Antonia Montesu, Giacomo Caldarola. Risankizumab: Daily Practice Experience of High Need PatientsBiomedicines 2023; 11(6): 1769 doi: 10.3390/biomedicines11061769
37
Liliana Baroiu, Lucreția Anghel, Alin Tatu, Alina Iancu, Caterina Dumitru, Ana-Cristina Leșe, Miruna Drăgănescu, Florentina Năstase, Elena Niculeț, Silvia Fotea, Aurel Nechita, Doina Voinescu, Anca Stefanopol. Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID‑19 (Review)Experimental and Therapeutic Medicine 2022; 23(6) doi: 10.3892/etm.2022.11312
38
Leena Chularojanamontri, Supot Nimanong, Chanisada Wongpraparut, Narumol Silpa-Archa, Chayada Chaiyabutr, Norramon Charoenpipatsin. How do we treat psoriasis patients with hepatitis C infections in real-world situations? A retrospective analysis of 34 patientsJournal of Dermatological Treatment 2021; 32(3): 321 doi: 10.1080/09546634.2019.1657225